Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds

Among all immunological subtypes, γδT cells stand out in an unbiased computational analysis for their association with improved overall survival of patients with many different tumor types.[1][1] γδT cells are innate like T cells that are present in both blood and tissue and are known to be